Target Capillary Blood Glucose in ICU Patients
The target capillary blood glucose range for ICU patients should be 140-180 mg/dL (7.8-10 mmol/L), with insulin therapy initiated for persistent hyperglycemia ≥180 mg/dL (10 mmol/L). 1
Insulin Initiation Threshold
The 2024 Society of Critical Care Medicine guidelines provide clear direction on when to start glycemic management 1:
- Initiate insulin therapy when blood glucose is persistently ≥180 mg/dL (10 mmol/L) - defined as two consecutive readings at or above this level
- This trigger threshold is intentionally set at the upper limit of the target range to avoid prolonged periods of hyperglycemia while minimizing hypoglycemia risk
- The rationale is that significant hyperglycemia causes osmotic complications and is associated with worse outcomes, though it also reflects illness severity and insulin resistance
Target Range During Treatment
Once insulin therapy is initiated, the evidence strongly supports moderate glucose control 1, 2:
- Target range: 140-180 mg/dL (7.8-10 mmol/L) for all ICU patients
- This recommendation is based on avoiding both the harms of tight control (increased hypoglycemia) and the complications of uncontrolled hyperglycemia
- Network meta-analysis of 35 studies with 18,098 patients found no mortality or infection benefit from tighter targets (<110 mg/dL or 110-144 mg/dL), but these lower targets increased hypoglycemia risk four to ninefold 3
Critical Pitfalls to Avoid
Hypoglycemia is particularly dangerous in the ICU setting:
- Even a single episode of mild hypoglycemia (<80 mg/dL) is associated with increased mortality and longer ICU stays 4
- Targets below 144 mg/dL significantly increase this risk without improving outcomes 3
Special consideration for diabetic patients:
- Diabetic ICU patients may benefit from slightly higher targets (10-14 mmol/L or 180-252 mg/dL) to avoid relative hypoglycemia - when ICU glucose drops >30% below their baseline premorbid levels 5
- This approach reduced relative hypoglycemia episodes from 50% to 22.5% of patients and decreased insulin requirements 5
Monitoring Approach
- Use arterial blood samples when available, followed by venous samples; avoid point-of-care capillary devices in critically ill patients due to accuracy concerns 1, 6
- Blood gas analyzers provide more reliable measurements at the bedside 7
- Monitor frequently (≤1 hour intervals) during periods of glycemic instability 1
Implementation Strategy
Use continuous intravenous insulin infusion with a standardized protocol that specifies 6:
- Treatment threshold: ≥180 mg/dL
- Target range: 140-180 mg/dL
- Insulin adjustment algorithms
- Monitoring frequency based on stability
This moderate approach represents the current international consensus, balancing the proven harms of both hyperglycemia and hypoglycemia while prioritizing patient safety and mortality reduction 2, 4.